Robuta

The inhibition of EPAC1, a cAMP-binding protein, appears as a potential therapeutic strategy to limit doxorubicin-induced cardiotoxicity without interfering...

Neurofibromatosis Type 1 (NF1)-related Malignant Peripheral Nerve Sheath Tumors (MPNST) are highly resistant sarcomas that account for significant mortality....

False-coloured scanning electron micrograph of a breast tumour spheroid (cluster of cells). The spheroid has been treated with the anti-cancer drug...

This large trial was for ovarian cancer that had come back after prior chemotherapy that included a platinum drug

Combining trabectedin (Yondelis) with doxorubicin helps people with leiomyosarcoma live longer than doxorubicin alone, new clinical trial results show.

Doxorubicin is a chemotherapeutic medication commonly used to treat many types of cancers, but it has side effects including vomiting, rash, hair loss, and...

Doxorubicin (DOXO) is one of the most widely used antineoplastic drugs. Despite its highly beneficial effects against several malignancies, the clinical use of...

Triple-negative breast cancer (TNBC) is an aggressive malignancy in which the tumors lack expression of estrogen receptor, progesterone receptor, and HER2....

Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients with Locally Advanced TNBC with Tumors Predicted Insensitive to Standard Chemotherapy; A...

Ovarian cancer is one of the most lethal gynecological malignancies. Recurrence or acquired chemoresistance is the leading cause of ovarian cancer therapy fa...